Hospitals & Providers

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.

Is interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.

Find out what worked for this value-based physician and hospital network and Accountable Care Organization in Massachusetts.

How can we as an industry help address the growing need and demand for quality mental health services? One of the more promising solutions is the expanded use of certified physician assistants.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

An Epstein Becker Green survey has surprising results about the expansion of telehealth services physicians and other behavioral health professionals can provide.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

A new study has unbelievable findings about treating Medicare patients with diabetes.

As genomics continues to evolve, here are five things to know about genetic testing and counseling.

A survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.

A Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.

With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.

CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.

One expert says incentive programs to motivate physicians miss the mark. Here’s what he recommends instead.

As the healthcare system shifts from a focus on employee-based plans to consumer-based plans, insurers have to find new ways to engage and motivate members.

Providers are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.

Avalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.

Why researchers say the industry is “a long way off” from robust electronic patient data sharing.

Trump takes two steps to dissolve the ACA. Find out what the experts think about these two important actions.

Here’s a quick guide to the meaning behind Trump’s executive order and decision to stop cost-sharing reduction payments.

The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.